SC

Saravanan Chitra

Active Director Director DIN 10145056
DIN 10145056 First appointment May 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Saravanan Chitra

Data last updated:

Saravanan Chitra is a Director at Triumph Pharmacy Services Private Limited (since 2023) and Director at Trimperor Pharma Private Limited (since 2023). The companies operate in Pharma and Paper.

DIN 10145056
Primary Designation Director
Industry Pharma
First Appointment 02 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Oct 20232023Active
Trimperor Pharma Private Limited U21002TN2023PTC160088
Director02 May 20232023Active

Board colleagues of Saravanan Chitra

Directorship timeline

Open interactive timeline →
Trimperor Pharma Private Limited
Triumph Pharmacy Services Private Limited
Premium access

Shareholding and investment profile for Saravanan Chitra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saravanan Chitra

Saravanan Chitra currently holds 2 directorships: Triumph Pharmacy Services Private Limited (Director, since 16 Oct 2023); Trimperor Pharma Private Limited (Director, since 02 May 2023).

Saravanan Chitra was first appointed on 02 May 2023 as Director at Trimperor Pharma Private Limited.

The current boards of Saravanan Chitra's companies include Manipandi Saravanan (Triumph Pharmacy Services Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available